Eur Rev Med Pharmacol Sci 2020; 24 (13): 7199-7199
DOI: 10.26355/eurrev_202007_21849

MicroRNA-29 targets FGF2 and inhibits the proliferation, migration and invasion of nasopharyngeal carcinoma cells via PI3K/AKT signaling pathway

M. Xu, G.-L. Tian, C.-C. Hao, M. Shi, D.-J. Zha, K. Liang

Department of Radiation Oncology, Air Force Medical University, Xi’an, Shaanxi, China.


The article “MicroRNA-29 targets FGF2 and inhibits the proliferation, migration and invasion of nasopharyngeal carcinoma cells via PI3K/AKT signaling pathway, by M. Xu, G.-L. Tian, C.-C. Hao, M. Shi, D.-J. Zha, K. Liang, published in Eur Rev Med Pharmacol Sci 2019; 23 (12): 5215-5222. DOI: 10.26355/eurrev_201906_18186. PMID: 31298371” has been withdrawn from the authors.

The Publisher apologizes for any inconvenience this may cause.

MicroRNA-29 targets FGF2 and inhibits the proliferation, migration and invasion of nasopharyngeal carcinoma cells via PI3K/AKT signaling pathway

Free PDF Download

To cite this article

M. Xu, G.-L. Tian, C.-C. Hao, M. Shi, D.-J. Zha, K. Liang
MicroRNA-29 targets FGF2 and inhibits the proliferation, migration and invasion of nasopharyngeal carcinoma cells via PI3K/AKT signaling pathway

Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 13
Pages: 7199-7199
DOI: 10.26355/eurrev_202007_21849